Health Catalyst, Inc. — Director's Dealing 2021

Apr 19, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Health Catalyst, Inc. (HCAT)
CIK: 0001636422
Period of Report: 2021-04-15

Reporting Person: Orenstein Daniel H. (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-04-15	Common Stock	M	3500.00	$10.34	Acquired	84046.00	Direct
2021-04-15	Common Stock	S	3476.00	$51.2801	Disposed	80570.00	Direct
2021-04-15	Common Stock	S	24.00	$51.8433	Disposed	80546.00	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-04-15	Stock Option (Right to Buy)	$10.34	M	3500.00	Disposed	2026-02-10	Common Stock (3500.00)	Direct

Footnotes

F1: The sales reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on March 4, 2020, in accordance with Rule 10b5-1.

F2: Represents the weighted average sale price of the shares sold ranging from $50.63 to $51.62 per share, inclusive.

F3: Represents a weighted average price. These shares were sold by the Reporting Person in multiple transactions at prices ranging from $51.84 to $51.85, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in Footnotes (2) and (3).

F4: 25% of the shares vested on December 31, 2016 and the remaining 75% vested in 36 equal monthly installments thereafter until the option was vested in full on Dec. 31, 2019.